Baxter Bros Inc. Sells 2,413 Shares of Procter & Gamble Company (The) $PG

Baxter Bros Inc. trimmed its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.6% during the 2nd quarter, Holdings Channel reports. The firm owned 90,593 shares of the company’s stock after selling 2,413 shares during the period. Procter & Gamble comprises 1.8% of Baxter Bros Inc.’s investment portfolio, making the stock its 18th biggest position. Baxter Bros Inc.’s holdings in Procter & Gamble were worth $14,433,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of PG. Brighton Jones LLC grew its stake in Procter & Gamble by 51.5% during the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after acquiring an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. grew its stake in shares of Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after buying an additional 277 shares in the last quarter. Wedge Capital Management L L P NC grew its stake in shares of Procter & Gamble by 2.9% in the 1st quarter. Wedge Capital Management L L P NC now owns 4,138 shares of the company’s stock worth $705,000 after buying an additional 116 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Procter & Gamble by 22.4% in the 1st quarter. GAMMA Investing LLC now owns 46,658 shares of the company’s stock worth $7,951,000 after buying an additional 8,537 shares in the last quarter. Finally, Atwood & Palmer Inc. grew its stake in shares of Procter & Gamble by 0.9% in the 1st quarter. Atwood & Palmer Inc. now owns 22,463 shares of the company’s stock worth $3,828,000 after buying an additional 205 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on PG. Wells Fargo & Company dropped their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Barclays dropped their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $170.00 price target (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, UBS Group dropped their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research note on Wednesday. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $172.58.

Insider Transactions at Procter & Gamble

In other news, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at $8,279,007.34. The trade was a 18.11% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by corporate insiders.

Procter & Gamble Trading Down 1.2%

NYSE:PG opened at $150.67 on Thursday. The firm has a 50-day simple moving average of $155.26 and a 200-day simple moving average of $159.72. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The firm has a market cap of $352.64 billion, a P/E ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the firm earned $1.40 EPS. The company’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.